Neurogenic bladder
Conditions
Interventions
Control group:Conventional rehabilitation therapy
Central combined with peripheral regulation group (rTMS+rPMS group):Transcranial magnetic stimulation combined with Peripheral magnetic stimulation( sacral 3 nerve)
rPMS group:Peripheral magnetic stimulation( sacral 3 nerve)
Sponsors
Affiliated Hospital of Nantong University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.The patient met the diagnostic criteria for stroke in the "Key Points for the Diagnosis of Major Cerebrovascular Diseases in China 2019 Edition" and was confirmed by cranial CT or MRI examination; 2.The first stroke and in the subacute stage (with a course of 14 days to 3 months; 3.The clinical diagnosis was post-stroke urinary retention, and it was diagnosed in accordance with the "Expert Consensus on the Diagnosis and Treatment of Neurogenic Bladder After Stroke"; 4.Aged between 18 to 85 years old; 5.The patient can cooperate with the examination and treatment, and has good compliance; 6.Patients and their families voluntarily participated and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Urinary retention caused by other reasons before stroke (such as urinary system tumors, stones or moderate to severe benign prostatic hyperplasia, etc.); 2.Patients with severe urinary tract infections or hydronephrosis and other contraindications for intermittent catheterization and urinary system examination; 3.There are serious diseases such as heart, lung, liver and kidney damage, and they cannot tolerate them; 4.There are severe mental disorders, cognitive disorders or speech disorders, etc; 5.Those with implanted pacemakers or metal internal fixators in their bodies; 6.Patients with contraindications to magnetic stimulation therapy; 7.Patients with unstable conditions (unstable vital signs and/or progression of the disease within 48 hours).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Residual urine volume; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pelvic floor function;Vital sign parameters;Quality of life index;Urination record indicators;Maximum detrusor pressure;Maximum bladder capacity;Effective rate of treatment; | — |
Countries
China
Contacts
Public ContactSu Liu
Affiliated Hospital of Nantong University
Outcome results
None listed